Presentation Information
[O6-05]Vaccine development using COVID-19-derived T cell epitope
*Hiroki Hayashi1, Satoshi Baba1,2, Hironori Nakagami1 (1. Department of Health Development and Medicine, Graduate School of Medicine, The University of Osaka (Japan), 2. Department of Geriatric and General Medicine, Graduate School of Medicine, The University of Osaka (Japan))
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
